Assessment of functional movement disorders

Update on current therapies for essential tremor

Clinical comparison of migraine with left- vs right-sided headache

P2B001: a slow-release drug for Parkinson’s disease

Pathophysiology of REM sleep behavior disorder

IgA: a new biomarker of demyelinating disease

CBT mobile apps to treat insomnia

Predictors of conversion from positive to negative MOG antibody status

Recent developments in migraine treatment

Blood pressure updates at ESOC 2023: INTERACT3 and OPTIMAL-BP

Predictors of recovery from post-stroke aphasia

SECRET trial: rivaroxaban for cerebral venous thrombosis

Interim data from ECST-2 trial challenges surgical guidelines for carotid stenosis

INTERACT3 results: care bundle improves outcomes in intracerebral hemorrhage

Three-month outcomes for patients with chronic pain using cannabis-based medical products

Diagnostic challenges in atypical parkinsonian disorders

The impact of diet and exercise on adult hippocampal neurogenesis

Advocating for medical cannabis access and acceptance in the UK

Circadian medicine: modifying the circadian rhythm to treat disease

Improvements to levodopa-based treatments for Parkinson’s disease

Advancing myasthenia gravis treatment: RAISE trial of zilucoplan

Anti-obesity drugs increase adult neurogenesis in the hypothalamus

Extracellular vesicles in Parkinson’s disease

ND0612 vs oral immediate-release levodopa/carbidopa in patients with PD and motor fluctuations

MND-SMART: the adaptive platform trial investigating potential treatments for MND